Adaptive Biotechnologies (ADPT)
(Real Time Quote from BATS)
$4.04 USD
0.00 (0.00%)
Updated Jul 22, 2024 01:08 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 5.71% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.29 |
Next Year | -1.02 |
EPS (TTM) | -1.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 38.52M | 40.78M | 167.72M | 211.02M |
# of Estimates | 5 | 4 | 5 | 5 |
High Estimate | 40.50M | 42.20M | 170.66M | 221.50M |
Low Estimate | 35.19M | 39.40M | 164.70M | 200.00M |
Year ago Sales | 48.93M | 37.92M | 170.28M | 167.72M |
Year over Year Growth Est. | -21.28% | 7.53% | -1.50% | 25.82% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.32 | -1.29 | -1.02 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.32 | -0.30 | -1.24 | -1.03 |
High Estimate | -0.27 | -0.30 | -1.24 | -0.79 |
Low Estimate | -0.36 | -0.34 | -1.32 | -1.26 |
Year ago EPS | -0.33 | -0.35 | -1.38 | -1.29 |
Year over Year Growth Est. | 3.03% | 8.57% | 6.52% | 20.74% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.32 | -1.29 | -1.02 |
7 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
30 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
60 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
90 Days Ago | -0.33 | -0.33 | -1.31 | -1.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.32 | -1.29 | -1.02 |
Zacks Consensus Estimate | -0.32 | -0.32 | -1.29 | -1.02 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.30 | -0.35 | -0.33 | NA |
Estimate | -0.35 | -0.32 | -0.32 | -0.33 | NA |
Difference | 0.02 | 0.02 | -0.03 | 0.00 | 0.00 |
Surprise | 5.71% | 6.25% | -9.38% | 0.00% | 0.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more